UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 204

Sortiert nach

Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati

Bone marrow transplantation (Basingstoke), 2020-10, Vol.55 (10), p.1900-1905

2020

Link zum Volltext

Verfügbarkeit prüfen

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

The New England journal of medicine, 2020-05, Vol.382 (19), p.1811-1822

2020

Link zum Volltext

Verfügbarkeit prüfen

L‐asparaginase treatment in acute lymphoblastic leukemia

Cancer, 2011-01, Vol.117 (2), p.238-249

2011

Link zum Volltext

Verfügbarkeit prüfen

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

Journal of clinical oncology, 2015-09, Vol.33 (27), p.2949-2962

2015

Link zum Volltext

Verfügbarkeit prüfen

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

Journal of clinical oncology, 2013-02, Vol.31 (5), p.599-607

2013

Link zum Volltext

Verfügbarkeit prüfen

Asparaginase pharmacokinetics and implications of therapeutic drug monitoring

Leukemia & lymphoma, 2015-08, Vol.56 (8), p.2273-2280

2015

Link zum Volltext

Verfügbarkeit prüfen

Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers

Cancers, 2022-01, Vol.14 (2), p.426

2022

Link zum Volltext

Verfügbarkeit prüfen

Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-09, Vol.7 (7), p.2476-2478.e5

2019

Link zum Volltext

Verfügbarkeit prüfen

Inotuzumab ozogamicin in older patients with acute lymphoblastic leukaemia: premises and promises

The lancet oncology, 2018-02, Vol.19 (2), p.159-160

Rizzari, Carmelo

2018

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium

Journal of clinical oncology, 2013-07, Vol.31 (19), p.2460-2468

2013

Link zum Volltext

Verfügbarkeit prüfen

Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion

ESMO open, 2020-09, Vol.5 (5), p.e000977-e000977, Article e000977

2020

Link zum Volltext

Verfügbarkeit prüfen

Ancestry and pharmacogenetics of antileukemic drug toxicity

Blood, 2007-05, Vol.109 (10), p.4151-4157

2007

Link zum Volltext

Verfügbarkeit prüfen

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK

Health science reports, 2024-01, Vol.7 (1), p.e1749-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child

Genes, 2022-02, Vol.13 (3), p.442

2022

Link zum Volltext

Verfügbarkeit prüfen

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO

Mediterranean journal of hematology and infectious diseases, 2022, Vol.14 (1), p.e2022027-e2022027

2022

Link zum Volltext

Verfügbarkeit prüfen

Still trying to pick the best asparaginase preparation

The lancet oncology, 2015-12, Vol.16 (16), p.1580-1581

Rizzari, Carmelo

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Results of a Randomized Trial on Extended Use of High Dose l-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2005-10, Vol.23 (28), p.7161-7167

2005

Link zum Volltext

Verfügbarkeit prüfen

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

EBioMedicine, 2022-09, Vol.83, p.104224-104224, Article 104224

2022

Link zum Volltext

Verfügbarkeit prüfen

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009‐2017)

HemaSphere, 2023-08, Vol.7 (S3), p.e1005163-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(201)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(127)
Humans
(105)
Child
(80)
Hematology
(80)
Male
(63)
Oncology
(63)
Child, Preschool
(52)
Female
(52)
Pediatrics
(49)
Adolescent
(44)
Infant
(37)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(35)
Leukemia
(30)
Acute Lymphoblastic Leukemia
(28)
Children
(28)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Patients
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

L‐asparaginase treatment in acute lymphoblastic leukemia

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial

Asparaginase pharmacokinetics and implications of therapeutic drug monitoring

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers

Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature

Inotuzumab ozogamicin in older patients with acute lymphoblastic leukaemia: premises and promises

Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium

Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion

Ancestry and pharmacogenetics of antileukemic drug toxicity

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK

Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child

A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study

FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO

Still trying to pick the best asparaginase preparation

Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis

Long-Term Results of a Randomized Trial on Extended Use of High Dose l-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009‐2017)

Suchergebnisse filtern